IMMU-12. THE HISTONE DEACETYLASE INHIBITOR VALPROIC ACID AUGMENTS THE SUSCEPTIBILITY OF ONCOLYTIC VIRUS-INFECTED GLIOBLASTOMA CELLS TO PD-1 BLOCKADE THERAPY

Oncolytic Herpes Simplex Virus-1(oHSV1) is currently being tested in clinical trials for the treatment of recurrent glioblastoma. Our group has previously shown that valproic acid (VPA), a pan Histone Deacetylase inhibitor (panHDACi) increases the cytotoxic effect of oHSV within tumor cells. VPA has...

全面介紹

Na minha lista:
書目詳細資料
發表在:Neuro Oncol
Main Authors: Alayo, Quazim, Passaro, Carmela, McNulty, John, Hiroshi, Nakashima, Chiocca, E Antonio
格式: Artigo
語言:Inglês
出版: Oxford University Press 2017
主題:
Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692912/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.471
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍